Clinical trial
3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer…
NCT00288093 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00288093 |
|---|---|
| Title | 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery |
| Official title | A Phase I Study of Triapine® in Combination With Radiation Therapy in Locally Advanced Pancreas Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 |
| Intervention type | Drug, Radiation |
| Interventions | 3-Dimensional Conformal Radiation Therapy, Triapine |
| Enrollment | 30 |
| Start date | Dec 20, 2006 |
| Primary completion | Dec 28, 2012 |
| Completion | Dec 28, 2012 |
| First posted | Feb 7, 2006 |
| Last update posted | Aug 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: